10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
PFIZER INC | ||
Ticker: PFE Fiscal Year: 2018 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2018 10-K (Filed: Feb 28, 2019) | ||
(In Millions, except shares in actual) | ||
As of | As of | |
Dec 31, 2018 | Dec 31, 2017 | |
Assets | ||
Cash and cash equivalents | $ 1,139 | 1,342 |
Short-term investments | 17,694 | 18,650 |
Trade accounts receivable, less allowance for doubtful accounts: 2018$541; 2017$584 | 8,025 | 8,221 |
Inventories | 7,508 | 7,578 |
Current tax assets | 3,374 | 3,050 |
Other current assets | 2,461 | 2,289 |
Assets held for sale | 9,725 | 12 |
Total current assets | 49,926 | 41,141 |
Long-term investments | 2,767 | 7,015 |
Property, plant and equipment, less accumulated depreciation | 13,385 | 13,865 [1] |
Identifiable intangible assets, less accumulated amortization | 35,211 | 48,741 |
Goodwill | 53,411 | 55,952 |
Noncurrent deferred tax assets and other noncurrent tax assets | 1,924 | 1,855 |
Other noncurrent assets | 2,799 | 3,227 |
Total assets | 159,422 | 171,797 |
Liabilities and Equity | ||
Short-term borrowings, including current portion of long-term debt: 2018$4,776; 2017$3,546 | 8,831 | 9,953 |
Trade accounts payable | 4,674 | 4,656 |
Dividends payable | 2,047 | 2,029 |
Income taxes payable | 1,265 | 477 |
Accrued compensation and related items | 2,397 | 2,196 |
Other current liabilities | 10,753 | 11,115 |
Liabilities held for sale | 1,890 | 0 |
Total current liabilities | 31,858 | 30,427 |
Long-term debt | 32,909 | 33,538 |
Pension benefit obligations, net | 5,272 | 5,926 |
Postretirement benefit obligations, net | 1,338 | 1,504 |
Noncurrent deferred tax liabilities | 3,700 | 3,900 |
Other taxes payable | 14,737 | 18,697 |
Other noncurrent liabilities | 5,850 | 6,149 |
Total liabilities | 95,664 | 100,141 |
Commitments and Contingencies | ||
Preferred stock, no par value, at stated value; 27 shares authorized; issued: 2018-478; 2017-524 | 19 | 21 |
Common stock, $0.05 par value; 12,000 shares authorized; issued: 2018-9,332; 2017-9,275 | 467 | 464 |
Additional paid-in capital | 86,253 | 84,278 |
Treasury stock, shares at cost: 20183,615; 2017-3,296 | (101,610) | (89,425) |
Retained earnings | 89,554 | 85,291 |
Accumulated other comprehensive loss | (11,275) | (9,321) |
Total Pfizer Inc. shareholders equity | 63,407 | 71,308 |
Equity attributable to noncontrolling interests | 351 | 348 |
Total equity | 63,758 | 71,656 |
Total liabilities and equity | 159,422 | 171,797 |
[1] The decrease in total property, plant and equipment is primarily due to depreciation, the reclassification of $675 million to Assets held for sale during the fourth quarter of 2018 (see Note 2C), reductions due to asset impairments largely associated with cost reduction initiatives not associated with acquisitions (see Note 3), and the impact of foreign exchange, partially offset by capital additions. |
External Links | |
PFIZER INC (PFE) Fiscal Year 2018 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |